The Beauty Health Company (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
1.460
+0.045 (3.18%)
Dec 20, 2024, 4:00 PM EST - Market closed
The Beauty Health Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 347.62 | 397.99 | 365.88 | 260.09 | 119.09 | 166.62 | Upgrade
|
| Revenue Growth (YoY) | -12.94% | 8.78% | 40.68% | 118.39% | -28.53% | 48.36% | Upgrade
|
| Cost of Revenue | 171.98 | 242.88 | 117.1 | 81.55 | 51.89 | 60.11 | Upgrade
|
| Gross Profit | 175.64 | 155.11 | 248.78 | 178.54 | 67.2 | 106.51 | Upgrade
|
| Selling, General & Admin | 246.49 | 275.93 | 266.18 | 210.27 | 80.97 | 88.44 | Upgrade
|
| Research & Development | 8.12 | 10.1 | 8.44 | 8.2 | 3.41 | 4.61 | Upgrade
|
| Operating Expenses | 254.61 | 286.03 | 274.62 | 218.47 | 84.38 | 93.05 | Upgrade
|
| Operating Income | -78.98 | -130.92 | -25.84 | -39.93 | -17.18 | 13.46 | Upgrade
|
| Interest Expense | -11.31 | -13.65 | -13.39 | -11.78 | -21.28 | -17.09 | Upgrade
|
| Interest & Investment Income | 20.82 | 23.17 | 9.18 | 0.04 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 2.95 | 2.39 | -1.3 | -0.07 | 0.02 | 0.16 | Upgrade
|
| Other Non Operating Income (Expenses) | 6.49 | 12.22 | 76.69 | -277.5 | -0.05 | 0.54 | Upgrade
|
| EBT Excluding Unusual Items | -60.03 | -106.79 | 45.34 | -329.24 | -38.48 | -2.94 | Upgrade
|
| Other Unusual Items | 33.4 | 4.9 | - | -51.4 | - | - | Upgrade
|
| Pretax Income | -26.63 | -101.89 | 45.34 | -380.64 | -38.48 | -2.94 | Upgrade
|
| Income Tax Expense | 1.54 | -1.77 | 1.12 | -1.88 | -9.31 | -1.3 | Upgrade
|
| Earnings From Continuing Operations | - | -100.12 | 44.22 | -378.76 | -29.18 | -1.64 | Upgrade
|
| Net Income | -28.17 | -100.12 | 44.22 | -378.76 | -29.18 | -1.64 | Upgrade
|
| Net Income to Common | -28.17 | -100.12 | 44.22 | -378.76 | -29.18 | -1.64 | Upgrade
|
| Shares Outstanding (Basic) | 125 | 132 | 148 | 102 | 34 | 32 | Upgrade
|
| Shares Outstanding (Diluted) | 125 | 132 | 149 | 102 | 34 | 32 | Upgrade
|
| Shares Change (YoY) | -6.82% | -11.33% | 45.43% | 197.77% | 6.71% | 65282.60% | Upgrade
|
| EPS (Basic) | -0.23 | -0.76 | 0.30 | -3.71 | -0.85 | -0.05 | Upgrade
|
| EPS (Diluted) | -0.43 | -0.76 | -0.23 | -3.71 | -0.85 | -0.05 | Upgrade
|
| Free Cash Flow | -6.22 | -0.53 | -118.92 | -39.56 | -15.94 | -7.05 | Upgrade
|
| Free Cash Flow Per Share | -0.05 | -0.00 | -0.80 | -0.39 | -0.46 | -0.22 | Upgrade
|
| Gross Margin | 50.53% | 38.97% | 68.00% | 68.65% | 56.43% | 63.92% | Upgrade
|
| Operating Margin | -22.72% | -32.89% | -7.06% | -15.35% | -14.43% | 8.08% | Upgrade
|
| Profit Margin | -8.10% | -25.16% | 12.09% | -145.63% | -24.50% | -0.98% | Upgrade
|
| Free Cash Flow Margin | -1.79% | -0.13% | -32.50% | -15.21% | -13.38% | -4.23% | Upgrade
|
| EBITDA | -41.88 | -96.24 | -2.97 | -22 | -2.69 | 27.26 | Upgrade
|
| EBITDA Margin | -12.05% | -24.18% | -0.81% | -8.46% | -2.25% | 16.36% | Upgrade
|
| D&A For EBITDA | 37.09 | 34.68 | 22.87 | 17.93 | 14.5 | 13.8 | Upgrade
|
| EBIT | -78.98 | -130.92 | -25.84 | -39.93 | -17.18 | 13.46 | Upgrade
|
| EBIT Margin | -22.72% | -32.89% | -7.06% | -15.35% | -14.43% | 8.08% | Upgrade
|
| Effective Tax Rate | - | - | 2.46% | - | - | - | Upgrade
|
| Advertising Expenses | - | 2.3 | 3.8 | 3.2 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.